|
2024
|
G/S
|
Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery... |
|
|
G/S
|
Drug delivery agents in the form of liquid for subcutaneous
delivery that facilitate the deliver... |
|
|
G/S
|
Drug delivery agents in the form of subcutaneous delivery that facilitate the delivery of pharmac... |
|
|
G/S
|
Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the deliver... |
|
|
Invention
|
Ph20 polypeptide variants, formulations and uses thereof. Modified PH20 hyaluronidase polypeptide... |
|
|
Invention
|
Hyaluronidase enzyme formulations for high volume administration.
In one aspect, the present dis... |
|
|
G/S
|
administration of a discount program enabling patients to obtain discounts on prescription drugs ... |
|
|
G/S
|
insurance benefits verification and prior authorization assistance; copay assistance programs, na... |
|
|
Invention
|
Methods of treating tumors.
The disclosure provides pharmaceutical compositions comprising an an... |
|
2023
|
Invention
|
Hyaluronidase enzyme formulations for high volume administration. In one aspect, the present disc... |
|
|
Invention
|
Antibody compositions and methods of use thereof.
The disclosure provides pharmaceutical composi... |
|
|
Invention
|
Ph20 polypeptide variants, formulations and uses thereof.
Modified PH20 hyaluronidase polypeptid... |
|
|
Invention
|
Ph20 polypeptide variants with a modification at position 309 of the ph20 polypeptide and a metho... |
|
|
Invention
|
Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceut... |
|
|
Invention
|
Dosing regimen.
Provided are combination dosing regimens comprising administering cabotegravir a... |
|
2022
|
Invention
|
Injection device |
|
|
Invention
|
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor.
Provi... |
|
2021
|
Invention
|
Methods of treating tumors. The disclosure provides pharmaceutical compositions comprising an ant... |
|
|
Invention
|
Antibody compositions and methods of use thereof. The disclosure provides pharmaceutical composit... |
|
|
Invention
|
Subcutaneous telomerase inhibitor compositions and methods for using same.
Aspects of the disclo... |
|
|
Invention
|
Subcutaneous telomerase inhibitor compositions and methods for using same. Aspects of the disclos... |
|
2020
|
Invention
|
Preparation of mammalian oocyte for fertilization via a soluble human ph20 hyaluronidase polypept... |
|
|
Invention
|
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions.
Prov... |
|
2019
|
Invention
|
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph... |
|
2018
|
Invention
|
Combination therapy with an anti-hyaluronan agent and therapeutic agent.
Provided herein is comb... |
|
|
Invention
|
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases. T... |
|
2017
|
Invention
|
Combination therapy with an anti-hyaluronan agent and therapeutic agent. Provided herein is combi... |
|
|
Invention
|
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and m... |
|
|
Invention
|
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor. Provid... |
|
2016
|
G/S
|
Patient recruitment services, namely, recruiting patients for participation in clinical trials; p... |
|
|
Invention
|
Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for a... |
|
2015
|
Invention
|
Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same. Provide... |
|
|
G/S
|
Scientific research and development services in the field of pharmaceuticals and drug delivery de... |
|
|
G/S
|
Scientific research, development and integration services
for pharmaceuticals and drug delivery ... |
|
|
G/S
|
scientific research and development services for the integration of technologies, therapies, and ... |
|
2012
|
G/S
|
Enzymes for medical purposes, namely, facilitating delivery
of fluids or pharmaceuticals, and ph... |
|
2011
|
G/S
|
Enzymes for medical purposes, namely, facilitating delivery of fluids or pharmaceuticals, and pha... |
|
2010
|
G/S
|
Enzymes for medical purposes, namely, facilitating delivery of pharmaceuticals, and pharmaceutica... |
|
|
G/S
|
Enzymes for medical purposes, namely, facilitating delivery
of pharmaceuticals, and pharmaceutic... |
|
2009
|
G/S
|
Hyaluronidase in injectable form. |
|
2006
|
G/S
|
Hyaluronidase in injectable form. |
|
2004
|
G/S
|
recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures |
|
2003
|
G/S
|
HYALURONIDASE IN INJECTABLE FORM |
